Gapping down
In reaction to disappointing earnings/guidance: CYH -22%, EXXI -21.3%, GPC -1.6%, STAR -1%
Select metals/mining stocks trading lower: HMY -8%, AU -7.4%, AUY -7.1%, GFI -7%, GG -5.7%, SBGL -5.4%, IAG-5.3%, ABX -5.3%, NEM -5.3%, GOLD -5.1%, GDX -4.3%, PAAS -3.5%, AG -3.5%, AEM -3.2%, SLW -2.9%, SLV -2.3%,GLD -2%, BBL -1.3%
Other news: TNXP -35.4% (reports Phase 2 proof-of-concept clinical study of TNX-201 did not achieve its primary efficacy endpoint), GOGO -26.5% (responds to declaratory judgment action filed against it by American Airlines (AAL) last Friday),EMES -8.6% (to not make Q4 distribution), UHS -5.1% (in symp with CYH), DB -4.5% (cont vol pre-mkt), THC -4.2% (in symp with CYH), BCS -1.4% (likely in symp with DB)
Analyst comments: BTU -3.3% (downgraded to Underweight at BB&T Capital Mkts), CS -3.1% (downgraded to Neutral at JP Morgan)
In reaction to disappointing earnings/guidance: CYH -22%, EXXI -21.3%, GPC -1.6%, STAR -1%
Select metals/mining stocks trading lower: HMY -8%, AU -7.4%, AUY -7.1%, GFI -7%, GG -5.7%, SBGL -5.4%, IAG-5.3%, ABX -5.3%, NEM -5.3%, GOLD -5.1%, GDX -4.3%, PAAS -3.5%, AG -3.5%, AEM -3.2%, SLW -2.9%, SLV -2.3%,GLD -2%, BBL -1.3%
Other news: TNXP -35.4% (reports Phase 2 proof-of-concept clinical study of TNX-201 did not achieve its primary efficacy endpoint), GOGO -26.5% (responds to declaratory judgment action filed against it by American Airlines (AAL) last Friday),EMES -8.6% (to not make Q4 distribution), UHS -5.1% (in symp with CYH), DB -4.5% (cont vol pre-mkt), THC -4.2% (in symp with CYH), BCS -1.4% (likely in symp with DB)
Analyst comments: BTU -3.3% (downgraded to Underweight at BB&T Capital Mkts), CS -3.1% (downgraded to Neutral at JP Morgan)